| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/2010 | US20100130424 Crhr2 peptide agonists and uses thereof |
| 05/27/2010 | US20100130423 Treatment of myeloproliferative disorders with adaptor protein lnk |
| 05/27/2010 | US20100130422 Use of cocoa extract |
| 05/27/2010 | US20100130421 Biomodulators for treatment or prevention of disease |
| 05/27/2010 | US20100130420 Novel chimeric ligand-gated ion channels and methods of use thereof |
| 05/27/2010 | US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor |
| 05/27/2010 | US20100130418 P2X7 Inhibition Of Epithelial Cancers And Papillomas |
| 05/27/2010 | US20100130417 Transforming growth factor alpha hii |
| 05/27/2010 | US20100130416 Modulation of angiogenesis by a-beta peptide fragments |
| 05/27/2010 | US20100130415 Stem cell secreted product derived compositions for wound treatment |
| 05/27/2010 | US20100130414 Methods of Using E2F2 for the Treatment of Hypertension |
| 05/27/2010 | US20100130413 Treatment for age-related macular degeneration and other diseases of the eye |
| 05/27/2010 | US20100130412 Compositions to prevent and treat type-1 diabetes |
| 05/27/2010 | US20100130411 Method for treating cartilage disorders |
| 05/27/2010 | US20100130410 Neural regeneration peptides and methods for their use |
| 05/27/2010 | US20100130409 Cyclic peptide cxcr4 antagonists |
| 05/27/2010 | US20100130408 Use of modified cyclosporins |
| 05/27/2010 | US20100130407 Facilitation of resuscitation from cardiac arrest by erythropoietin |
| 05/27/2010 | US20100130406 Glycated milk and uses thereof |
| 05/27/2010 | US20100130405 Biglycan and related therapeutics and methods of use |
| 05/27/2010 | US20100130404 Biomarkers for cardiodiabetes |
| 05/27/2010 | US20100130403 Biomarkers for insulin efficacy |
| 05/27/2010 | US20100130402 Biomarkers for insulin resistance and beta-cell dysfunction |
| 05/27/2010 | US20100130401 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atheroscleroris |
| 05/27/2010 | US20100129901 Hepatitis c virus vaccine |
| 05/27/2010 | US20100129868 Delta 4,5 glycuronidase compositions and methods related thereto |
| 05/27/2010 | US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof |
| 05/27/2010 | US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 05/27/2010 | US20100129471 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization |
| 05/27/2010 | US20100129461 Process for Dispersing Amino Acids |
| 05/27/2010 | US20100129459 biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof |
| 05/27/2010 | US20100129453 Emulsions comprising rubber arabicum |
| 05/27/2010 | US20100129450 Electrospun Cell Matrices |
| 05/27/2010 | US20100129439 Adjuvant Incorporation in Immunonanotherapeutics |
| 05/27/2010 | US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA |
| 05/27/2010 | US20100129437 Targeted intracellular delivery of antiviral agents |
| 05/27/2010 | US20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 05/27/2010 | US20100129434 Compositions and methods for the treatment of mucormycosis and other fungal diseases |
| 05/27/2010 | US20100129428 Supra molecular construct for delivery of interferon to a mammal |
| 05/27/2010 | US20100129420 Methods and devices to accelerate wound healing in thoracic anastomosis applications |
| 05/27/2010 | US20100129419 Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
| 05/27/2010 | US20100129415 Bone regeneration device |
| 05/27/2010 | US20100129409 Novel Prostate Kallikrein Allergen |
| 05/27/2010 | US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
| 05/27/2010 | US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support |
| 05/27/2010 | US20100129384 Taci-immunoglobulin fusion proteins |
| 05/27/2010 | US20100129375 Methods for inhibiting ocular angiogenesis |
| 05/27/2010 | US20100129374 Mammalian Cell Membrane Proteins; Related Reagents |
| 05/27/2010 | US20100129372 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia |
| 05/27/2010 | US20100129368 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof |
| 05/27/2010 | US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such |
| 05/27/2010 | US20100129366 Thiazole inhibitors of cyclooxygenase |
| 05/27/2010 | US20100129364 Combination therapy for the treatment of ocular neovascular disorders |
| 05/27/2010 | US20100129359 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 05/27/2010 | US20100129352 Novel pharmaceutical composition |
| 05/27/2010 | US20100129351 Compositions and Methods for Altering Pancreas or Liver Function |
| 05/27/2010 | US20100129350 Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives |
| 05/27/2010 | US20100129348 Method for decreasing depression by inhibiting the activity of alpha 1b subunit of n-type calcium channel |
| 05/27/2010 | US20100129347 Herpes virus infection inhibitor, method for inhibiting infection with herpes virus, and use thereof |
| 05/27/2010 | US20100129345 Screening method for prokinetic agent |
| 05/27/2010 | US20100129344 Medical uses and therapies based upon the action of azurocidin on igfbp-1 |
| 05/27/2010 | US20100129343 Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface |
| 05/27/2010 | US20100129342 Human Growth and Differentiation Factor GDF-5 |
| 05/27/2010 | US20100129341 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 05/27/2010 | US20100129332 Methods and pharmaceutical compositions for healing wounds |
| 05/27/2010 | US20100129324 biological effects of compositions comprising rosmarinic acid |
| 05/27/2010 | US20100129321 Diaryl urea for treating virus infections |
| 05/27/2010 | US20100129320 Quinoline derivatives for modulating dna methylation |
| 05/27/2010 | US20100129319 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor |
| 05/27/2010 | US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses |
| 05/27/2010 | US20100129317 Azole nucleosides and use as inhibitors of rna and dna viral polymerases |
| 05/27/2010 | US20100129316 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 05/27/2010 | US20100129315 Anti-MN Antibodies and Methods of Using Same |
| 05/27/2010 | US20100129314 Potent conjugates and hydrophilic linkers |
| 05/27/2010 | US20100129313 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 05/27/2010 | US20100129311 Phenylalanine amide inhibitors of atp-sensitive potassium channels |
| 05/27/2010 | US20100129294 Nattokinase for degrading and reducing amyloid fibrils assoicated with alzheimer's disease, prion diseases and other amyloidoses |
| 05/27/2010 | US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same |
| 05/27/2010 | CA2744174A1 Snake factor v and methods of use as a procoagulant |
| 05/27/2010 | CA2744150A1 Novel form of administering osteogenic protein complexes |
| 05/27/2010 | CA2744134A1 New therapy and medicament using integrin ligands for treating cancer |
| 05/27/2010 | CA2743959A1 Liposomal composition for convection-enhanced delivery to the central nervous centre |
| 05/27/2010 | CA2743950A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor |
| 05/27/2010 | CA2743913A1 Inhibition of apoe cleavage activity in the treatment of apoe-related disorders |
| 05/27/2010 | CA2743912A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus |
| 05/27/2010 | CA2743436A1 Pathways to generate hair cells |
| 05/27/2010 | CA2743406A1 Fracture repair promoter |
| 05/27/2010 | CA2743177A1 Peptidomimetic macrocycles with improved properties |
| 05/27/2010 | CA2743172A1 Crystalline form of linaclotide |
| 05/27/2010 | CA2742753A1 Lantibiotic carboxyamide derivatives with enhanced antibacterial activity |
| 05/26/2010 | EP2189523A1 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
| 05/26/2010 | EP2189522A1 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
| 05/26/2010 | EP2189471A1 Foxm1 peptide and medicinal agent comprising the same |
| 05/26/2010 | EP2189470A1 Tumor antigens |
| 05/26/2010 | EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions |
| 05/26/2010 | EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition |
| 05/26/2010 | EP2188308A1 High yield secretion of multimeric recombinant protein |
| 05/26/2010 | EP2188304A1 Detection and quantitation of urine gelsolin |
| 05/26/2010 | EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |